The expression level of HER3 ligand heregulin mRNA as a predictive biomarker for anti-HER3 antibody patritumab combined with erlotinib in non-small cell lung cancer.
Kimio Yonesaka
No relevant relationships to disclose
Hisato Kawakami
No relevant relationships to disclose
Hiroyasu Kaneda
No relevant relationships to disclose
Isamu Okamoto
No relevant relationships to disclose
Kenji Hirotani
Employment or Leadership Position - Daiichi Sankyo
Kazuto Nishio
No relevant relationships to disclose
Kazuhiko Nakagawa
No relevant relationships to disclose